Palifermin Drug Interactions
Currently displaying a list of 132 drugs known to interact with palifermin.
- 1 major drug interaction
- 131 moderate drug interactions
Medications known to interact with palifermin
Note: Showing generic names only.
A
B
- belinostat
- bendamustine
- bevacizumab
- bexarotene
- bleomycin
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- busulfan
C
- cabazitaxel
- cabozantinib
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- chlorambucil
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- cobimetinib
- copanlisib
- crizotinib
- cyclophosphamide
- cytarabine
D
- dacarbazine
- dactinomycin
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- docetaxel
- doxorubicin
- doxorubicin liposomal
- duvelisib
E
F
G
H
I
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- ifosfamide
- imatinib
- inotuzumab ozogamicin
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon gamma-1b
- iobenguane I 131
- irinotecan
- irinotecan liposomal
- ixabepilone
L
M
- mechlorethamine
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- mitomycin
- mitoxantrone
- mosunetuzumab
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pazopanib
- peginterferon alfa-2a
- peginterferon alfa-2b
- pemetrexed
- pentostatin
- plicamycin
- pomalidomide
- ponatinib
- pralatrexate
- procarbazine
Q
R
S
T
- talazoparib
- teclistamab
- temozolomide
- teniposide
- thalidomide
- thioguanine
- thiotepa
- topotecan
- trabectedin
- trastuzumab
- trimetrexate
U
V
More about palifermin
- palifermin consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.